scutellarin has been researched along with Alloxan Diabetes in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Ding, M; Sun, L; Xie, X; Zhu, D | 1 |
| Qi, XM; Shen, JJ; Wu, YG; Xu, XX; Zhang, P; Zhang, W | 1 |
| Liu, X; Qi, F; Wu, W | 1 |
| Chen, KP; Chen, SX; Chen, YC; Fan, TL; Jia, JH; Liu, KZ | 1 |
| Fu, GS; Wang, M; Zhang, WB; Zhou, BQ; Zhu, JH | 2 |
| Lin, H; Lin, SY; Qi, XM; Shen, JJ; Wu, GZ; Wu, YG | 1 |
| Lin, H; Lin, ST; Qian, H; Wu, YG; Xia, LL; Zhou, D | 1 |
| Aini, M; Cai, R; Gao, Z; Huo, Y; Mijiti, A; Qie, R; Wang, Z | 1 |
| Hu, Y; Ke, Z; Li, W; Li, X; Li, Y; Long, L; Long, T; Wang, L; Xiao, H; Ye, X; Yu, S | 1 |
| Chen, R; Ma, X; Sun, G; Sun, X; Xu, L; Zhang, X; Zhu, Y | 1 |
| Ji, L; Lu, B; Mei, X; Ouyang, H; Wang, Z; Zhang, T | 1 |
| Liu, XF; Luo, P; Mo, ZJ; Tan, ZH; Zhang, H; Zhang, ZF | 1 |
| Liu, W; Liu, X; Liu, Z; Ma, L; Su, Y; Zhu, B | 1 |
14 other study(ies) available for scutellarin and Alloxan Diabetes
| Article | Year |
|---|---|
Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Mice; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Podocytes; Pyroptosis; Rats | 2023 |
Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Flavonoids; Kidney; Male; Phytotherapy; Random Allocation; Rats; Rats, Wistar; Transforming Growth Factor beta1 | 2013 |
Effect of intervention in the diacylglycerol‑protein kinase C signaling pathway on JNK1 expression and its downstream signaling in diabetic cardiomyopathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diglycerides; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Insulin Receptor Substrate Proteins; Mitogen-Activated Protein Kinase 8; Myocardium; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |
Breviscapine, a traditional Chinese medicine, alleviates myocardial ischaemia reperfusion injury in diabetic rats.
Topics: Adenosine Triphosphatases; Animals; Diabetes Mellitus, Experimental; Flavonoids; Glutathione Peroxidase; Immunohistochemistry; Intercellular Adhesion Molecule-1; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2008 |
Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway.
Topics: Animals; Cell Size; Cells, Cultured; Diabetes Mellitus, Experimental; Down-Regulation; Flavonoids; Glucose; Heart; Hypertrophy; Male; Myocardium; Myocytes, Cardiac; NF-kappa B; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2009 |
Breviscapine ameliorates cardiac dysfunction and regulates the myocardial Ca(2+)-cycling proteins in streptozotocin-induced diabetic rats.
Topics: Animals; Calcium; Calcium-Binding Proteins; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Flavonoids; Gene Expression; Heart; Humans; Intracellular Signaling Peptides and Proteins; Male; Myocardium; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2010 |
Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats.
Topics: Animals; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Flavonoids; Intercellular Adhesion Molecule-1; Kidney Glomerulus; Macrophages; Male; Oxidative Stress; Rats | 2006 |
Prevention of early liver injury by breviscapine in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Diabetes Complications; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Erigeron; Flavonoids; Lipid Metabolism; Lipid Peroxidation; Liver Diseases; Male; Malondialdehyde; Plants, Medicinal; Rats; Rats, Sprague-Dawley | 2007 |
Scutellarin alleviates type 2 diabetes (HFD/low dose STZ)-induced cardiac injury through modulation of oxidative stress, inflammation, apoptosis and fibrosis in mice.
Topics: Animals; Apigenin; Apoptosis; Biomarkers; Blood Glucose; Body Weight; Cardiovascular Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucuronates; Heart Diseases; Inflammation; Lipids; Male; Mice; Oxidative Stress; RNA, Messenger | 2021 |
Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling.
Topics: Angiogenesis Inhibitors; Animals; Apigenin; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Down-Regulation; Endothelial Cells; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Glucuronates; Humans; Male; Rats; Rats, Sprague-Dawley; Signal Transduction; src-Family Kinases; Streptozocin; Vascular Endothelial Growth Factor A | 2019 |
Scutellarin protects against diabetic cardiomyopathy via inhibiting oxidative stress and inflammatory response in mice.
Topics: Animals; Apigenin; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glucuronates; Mice; Mice, Inbred C57BL; Oxidative Stress | 2021 |
Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
Topics: Animals; Apigenin; Blood-Retinal Barrier; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Glucose; Glucuronates; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Microglia; NF-E2-Related Factor 2; Oxidative Stress; Retina; Tumor Necrosis Factor-alpha | 2019 |
Scutellarin isolated from Erigeron multiradiatus inhibits high glucose-mediated vascular inflammation.
Topics: Animals; Apigenin; Arteritis; Cell Adhesion; Cells, Cultured; Chemokine CCL2; Diabetes Mellitus, Experimental; Endothelium, Vascular; Erigeron; Glucose; Glucuronates; Humans; Hyperglycemia; Intercellular Adhesion Molecule-1; Mice; NF-kappa B; Phytotherapy | 2008 |
Scutellarin inhibits translocation of protein kinase C in diabetic thoracic aorta of the rat.
Topics: Animals; Aorta, Thoracic; Apigenin; Cells, Cultured; Diabetes Mellitus, Experimental; Glucuronates; Male; Protein Kinase C; Protein Kinase Inhibitors; Protein Transport; Rats; Rats, Wistar | 2012 |